33 results
SC 14D9
SGTX
Sigilon Therapeutics Inc
13 Jul 23
Tender offer solicitation
8:18am
of such determination or assessment, each party bears its own expenses. Determinations by the Delaware Court are subject to appellate review by the Supreme
SC TO-T
EX-99
SGTX
Sigilon Therapeutics Inc
13 Jul 23
Third party tender offer statement
8:01am
, (D) extend or waive the application of any statute of limitations regarding the assessment or collection of any material tax with respect to Sigilon
8-K
EX-2.1
SGTX
Sigilon Therapeutics Inc
29 Jun 23
Lilly to Acquire Sigilon Therapeutics
7:03am
noncompliance) with any applicable Law or (B) any material fine, assessment or cease and desist order, or the suspension, revocation or limitation … of Tax Return in that jurisdiction.
(f) There has been no waiver or extension of any applicable statute of limitations for the assessment or collection
8-K
EX-99.2
veo vucdf0n
10 Nov 22
Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
7:37am
8-K
EX-99.1
u5yjx7307t76qd
11 Oct 22
Regulation FD Disclosure
8:30am
10-Q
ge75uyzz7mw gs
10 May 21
Quarterly report
4:31pm
DEF 14A
8ye70jfiuh7lr8xra10
27 Apr 21
Definitive proxy
4:49pm
10-K
4j60al32x1r 0uo
18 Mar 21
Annual report
4:31pm
424B4
h879e bjg
7 Dec 20
Prospectus supplement with pricing info
9:10am
S-1/A
pujgxa4u7 80hbljri3r
30 Nov 20
IPO registration (amended)
6:41am